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EXPERT COMMENTARYA cancer staging primer: Esophagus and esophagogastric junctionThomas W. Rice, MD,a Eugene H. Blackstone, MD,a,b and Valerie W. Rusch, MDcStaging cancer of the esophagus and esophagogastric junc-
tion has been extensively changed and improved in the 7th
edition of the American Joint Committee on Cancer
(AJCC), Cancer Staging Manual.1 Changes address prob-
lems of empiric stage grouping and lack of harmonization
with stomach cancer. This was accomplished by assembling
worldwide data and using modern machine learning tech-
niques for data-driven staging.2-4 Improvements include
new definitions of Tis, T4, regional lymph node, N classifi-
cation, and M classification, and addition of the nonana-
tomic cancer characteristics: histopathologic cell type,
histologic grade, and cancer location. Stage groupings
were constructed by adherence to principles of staging, in-
cluding monotonic decreasing survival with increasing stage
group, distinct survival between groups, and homogeneous
survival within groups.CLASSIFICATIONS: CHANGES AND ADDITIONS
Primary tumor (T) classification has been changed for Tis
and T4 cancers (Figure 1, Table 1). Tis is now defined as
high-grade dysplasia and includes all noninvasive neoplastic
epithelium that was previously called carcinoma in situ. T4,
tumors invading local structures, has been subclassified as
T4a and T4b; T4a tumors are resectable cancers invading
adjacent structures, such as pleura, pericardium, or dia-
phragm. T4b are unresectable cancers invading other adja-
cent structures, such as aorta, vertebral body, or trachea.
Otherwise, T classifications are unchanged.
A regional lymph node has been redefined to include any
paraesophageal lymph node extending from cervical nodes
to celiac nodes (Table 1). Data analyses support convenient
coarse groupings of the number of cancer-positive nodes.2-4
Regional lymph node (N) classification comprises N0 (no
cancer-positive nodes), N1 (1 or 2), N2 (3–6), and N3
(7). N classifications for cancers of the esophagus and
esophagogastric junction are identical to stomach cancer N
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The Journal of Thoracic and CaThe subclassifications M1a and M1b have been elimi-
nated, as has MX (Table 1). Distant metastases are simply
designatedM0, no distant metastasis, andM1, distant metas-
tasis.
Nonanatomic cancer characteristics identified as impor-
tant for stage grouping were histopathologic cell type,
histologic grade (Table 1), and tumor location (Table 1;
Figure 2). Increasing histologic grade was associated with
incrementally decreasing survival for early-stage cancers.
For adenocarcinoma, the distinction of G1 and G2 (well
and moderately differentiated) cancers from G3 (poorly dif-
ferentiated) cancers was important for grouping stage I and
IIA cancers. For squamous cell carcinoma, the distinction
of G1 cancers from G2 and G3 cancers was important for
grouping stage I and II cancers. Uncommon G4 (undiffer-
entiated) cancers are staged as squamous cell carcinoma.
Tumor location (upper and middle thoracic esophagus vs
lower thoracic esophagus) was important for grouping
T2-3N0M0 squamous cell cancers.STAGE GROUPINGS
Stages 0 and IV are by definition (not data driven)
TisN0M0 and T any N any M1, respectively. Stage group-
ings for M0 adenocarcinoma are shown in Figure 3. For
T1N0M0 and T2N0M0 adenocarcinoma, subgrouping is
by histologic grade, G1, and G2 (not G3) versus G3. The
difference in survival between adenocarcinoma and squa-
mous cell carcinoma was best managed by separate stage
groupings for stages I and II.
Stage groupings for M0 squamous cell carcinoma are
shown in Figure 4. For T1N0M0 squamous cell carcinoma,
subgrouping is by histologic grade: G1 versus all other G
(Figure 4, A). For T2N0M0 and T3N0M0 squamous cell car-
cinoma, stage grouping is by histologic grade and location
(Figure 4, B). The 4 combinations range from G1 lower tho-
racic squamous cell carcinoma (stage IB), which has the best
survival, to G2 to G4 upper and middle thoracic squamous
cell carcinomas (stage IIB), which have the worst. G2 to
G4 lower thoracic squamous cell carcinomas and G1 upper
and middle thoracic squamous cell carcinomas are grouped
together (stage IIA) with intermediate survival.
Stage 0, III, and IV adenocarcinoma and squamous cell
carcinoma are identically stage grouped. Adenosquamous
carcinomas are staged as squamous cell carcinoma.ESOPHAGOGASTRIC JUNCTION CANCERS
In addition to being data driven, the 7th edition of the
AJCC Cancer Staging Manual harmonizes staging of cancer
across the esophagogastric junction. Previous staging editionsrdiovascular Surgery c Volume 139, Number 3 527
FIGURE 1. Seventh edition TNM classifications. T is classified as Tis: high-grade dysplasia; T1: cancer invades lamina propria, muscularis mucosae, or
submucosa; T2: cancer invades muscularis propria; T3: cancer invades adventitia; T4a: resectable cancer invades adjacent structures such as pleura, pericar-
dium, or diaphragm; and T4b; unresectable cancer invades other adjacent structures, such as aorta, vertebral body, or trachea. N is classified as N0: no regional
lymph node metastasis; N1: regional lymph node metastases involving 1 to 2 nodes; N2: regional lymph node metastases involving 3 to 6 nodes; and N3:
regional lymph node metastases involving 7 or more nodes. M is classified as M0: no distant metastasis; and M1: distant metastasis.
Expert Commentary Rice et alproduced different stages for these cancers depending on use
of either esophageal or gastric stage groupings. The 7th edition
staging is for cancers of the esophagus and esophagogastric
junction and includes cancer within the first 5 cm of the stom-
ach that invade the esophagogastric junction (Siewert III).
All other stomach cancers are staged groupings.TABLE 1. Summary of changes in anatomic classifications and
additions of nonanatomic cancer characteristics
Changes in anatomic classifications
T classification
Tis is redefined and T4 is subclassified
Tis high-grade dysplasia
T4a resectable cancer invades adjacent structures,
eg, pleura, pericardium, diaphragm
T4b unresectable cancer invades adjacent structures,
eg, aorta, vertebral body, trachea
N classification
Regional lymph node is redefined
Any periesophageal lymph node from cervical lymph
nodes to celiac node
N is classified
N0 no regional lymph node metastases
N1 1–2 positive regional lymph nodes
N2 3–6 positive regional lymph nodes
N3 7 positive regional lymph nodes
M classification
M is redefined
M0 no distant metastases
M1 distant metastases
528 The Journal of Thoracic and Cardiovascular SurgCONCLUSIONS
The new staging recommendations for cancer of the esopha-
gus and esophagogastric junction are data driven and harmo-
nized with stomach cancer. This required changes in TNM
definitions and addition of nonanatomic cancer characteristics.
For cancers of the esophagus and esophagogastric junction,TABLE 1. Continued










Upper thoracic 20–25 cm from incisors
Middle thoracic >25–30 cm from incisors
Lower thoracic >30–40 cm from incisors
Esophagogastric junction includes cancers whose epicenter is
(1) in the lower thoracic esophagus,
(2) in the esophagogastric junction, or
(3) within proximal 5 cm of the stomach
(cardia) that extend into the esophagogastric
junction or lower thoracic esophagus
ery c March 2010
FIGURE 2. Cancer location.Cervical esophagus, bounded superiorlyby the
cricopharyngeus and inferiorly by the sternal notch, is typically 15 to 20 cm
from the incisors at esophagoscopy. Upper thoracic esophagus, bounded su-
periorly by the sternal notch and inferiorly by the azygos arch, is typically
more than 20 to 25 cm from the incisors at esophagoscopy. Middle thoracic
esophagus, bounded superiorly by the azygos arch and inferiorly by the infe-
rior pulmonary vein, is typically more than 25 to 30 cm from the incisors at
esophagoscopy. Lower thoracic esophagus, bounded superiorly by the infe-
rior pulmonary vein and inferiorly by the lower esophageal sphincter, is typ-
ically more than 30 to 40 cm from the incisors at esophagoscopy; it includes
cancers whose epicenter is within the proximal 5 cm of the stomach that
extend into the esophagogastric junction or lower thoracic esophagus. UES,
Upper esophageal sphincter; EGJ, esophagogastric junction.
FIGURE 3. Stage groupings for M0 adenocarcinoma by T and N classifi-
cation and histologic grade (G).
FIGURE 4. Stage groupings for M0 squamous cell carcinoma. A, Stage
groupings for T1N0M0 and T2-3N0M0 squamous cell carcinomas by his-
tologic grade (G) and cancer location. B, Stage groupings for all other
M0 squamous cell carcinomas.
Rice et al Expert Commentary
The Journal of Thoracic and Castages 0, III, and IV are identical for both adenocarcinoma and
squamous cell carcinoma. However, stage groupings differ for
stage I and II cancers on the basis of histopathologic cell type,
histologic grade, and cancer location.
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